Coherus Oncology

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI.

CEO

Denny M. Lanfear

CEODenny M. Lanfear

Employees

228

Employees228

Headquarters

Redwood City, California

HeadquartersRedwood City, California

Founded

2010

Founded2010

Employees

228

Employees228

CHRS Key Statistics

Market cap

87.79M

Market cap87.79M

Price-Earnings ratio

-0.67

Price-Earnings ratio-0.67

Dividend yield

—

Dividend yield—

Average volume

1.35M

Average volume1.35M

High today

$0.7603

High today$0.7603

Low today

$0.72

Low today$0.72

Open price

$0.73

Open price$0.73

Volume

1.36M

Volume1.36M

52 Week high

$2.43

52 Week high$2.43

52 Week low

$0.6603

52 Week low$0.6603

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

42.9%

Sell

People also own

Based on the portfolios of people who own CHRS. This list is generated using Robinhood data, and it’s not a recommendation.